Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Inventory Average (2016 - 2026)

Corcept Therapeutics (CORT) has disclosed Inventory Average for 15 consecutive years, with $12.9 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average fell 3.82% year-over-year to $12.9 million; the TTM value through Mar 2026 reached $12.9 million, down 3.82%, while the annual FY2025 figure was $12.6 million, 25.51% up from the prior year.
  • Inventory Average hit $12.9 million in Q1 2026 for Corcept Therapeutics, up from $12.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $13.4 million in Q1 2025 and bottomed at $5.0 million in Q1 2022.
  • Average Inventory Average over 5 years is $8.7 million, with a median of $7.6 million recorded in 2023.
  • Year-over-year, Inventory Average skyrocketed 79.49% in 2025 and then fell 3.82% in 2026.
  • Corcept Therapeutics' Inventory Average stood at $6.1 million in 2022, then rose by 25.5% to $7.6 million in 2023, then skyrocketed by 34.24% to $10.2 million in 2024, then grew by 23.24% to $12.6 million in 2025, then grew by 2.15% to $12.9 million in 2026.
  • According to Business Quant data, Inventory Average over the past three periods came in at $12.9 million, $12.6 million, and $12.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.